SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Amazon Natural (AZNT)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Janice Shell who wrote (3615)9/4/1998 5:26:00 PM
From: Cavalry  Read Replies (1) of 26163
 
it is way too expensive in trial size bottle of $8.95, 20 cents a spoonful, larger bottles or production and mass distribution by a monsanto would drop price greatly, imo
bigger question is, will the medical studies coming out about the harmful effects of aspertame sway public sentiment enough to force the fda and sweetener industry to find new, less harmful alternative.
hoped once fighting subsided here we could discuss these types of issues.
the way fda approved aspertane and the way no new sweetener alternative can get fda approval is something worth discussing.

cavalry
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News